Stay updated with breaking news from German Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nimic nu este sigur și totul depinde de modul în care merg discuțiile de coaliție pentru formarea noului Guvern în Germania, informează...
Alman FAZ gazetesi: Türk otomobil endüstrisi güçleniyor 08:3011 Temmuz 2021 Alman FAZ gazetesi: Türk otomobil endüstrisi güçleniyor Alman Frankfurter Allgemeine Zeitung (FAZ), Türk otomobil endüstrisinin yeni tip koronavirüs (Kovid-19) salgınından sonra küresel konumunu güçlendirmeye çalıştığını kaydetti. A+A- Erzurum Güncel- Alman Frankfurter Allgemeine Zeitung (FAZ), Türk otomobil endüstrisinin yeni tip koronavirüs (Kovid-19) salgınından sonra küresel konumunu güçlendirmeye çalıştığını kaydetti. Gazete, "Türkiye sollama şeridine geçmek istiyor" ba...
5% Below are specific updates on pipeline assets since our previous earnings announcement on October 27, 2020: Abrocitinib (PF-04965842) — In November 2020, Pfizer announced positive top-line results from the fifth Phase 3 trial of abrocitinib, JADE REGIMEN, a 52-week study which investigated abrocitinib in patients 12 and older with moderate to severe atopic dermatitis (AD) following response to initial open label induction treatment with abrocitinib 200 mg. Patients were randomized into one of three arms: 200 mg, 100 mg or placebo. Both doses of abrocitinib met the primary endpoint, resu...
The UK and South African coronavirus mutations are spreading rapidly, fueling record surges in the two nations. The two strains are more infectious than other variants and have reached many other countries, with researchers and health officials worrying about their potential impact on vaccines. A new study shows that the Pfizer/BioNTech vaccine can neutralize the B.1.1.7 strain from the UK. Researchers from South Africa found that monoclonal...
study that evaluated one of the key mutations (N501Y) in the U.K. strain, which is also shared by the South African strain. That study showed efficient neutralization of the N501Y mutated spike bearing virus by sera of individuals who had received the Pfizer-BioNTech COVID-19 vaccine. The current in-vitro study investigated the full set of UK strain spike mutations. To this aim, a pseudovirus featuring the UK strain spike protein was generated. The pseudovirus recapitulates SARS-CoV-2 virus binding and cell entry. Sera of participants from the previously reported German Phase 1/2 trial i...